Skip to main content
. 2007 Dec 20;22(4):237–243. doi: 10.3904/kjim.2007.22.4.237

Table 3.

Comparison between patients with and without 'HBV reactivation'

graphic file with name kjim-22-237-i003.jpg

AC, adriamycin and cyclophosphamide; CAF, cyclophosphamide, adriamycin and 5-FU; AC→ T, AC followed by paclitaxel